中文名 | GSK-5959 |
英文名 | GSK-5959 |
别名 | 化合物GSK 5959 BRPF1BROMODOMAN抑制剂(GSK-5959) |
英文别名 | CS-1636 GSK5959 GSK-5959 BRPF1-IN-3 N-[2,3-Dihydro-1,3-dimethyl-2-oxo-6-(1-piperidinyl)-1H-benzimidazol-5-yl]-2-methoxybenzamide Benzamide, N-[2,3-dihydro-1,3-dimethyl-2-oxo-6-(1-piperidinyl)-1H-benzimidazol-5-yl]-2-methoxy- |
CAS | 901245-65-6 |
化学式 | C22H26N4O3 |
分子量 | 394.47 |
密度 | 1.263±0.06 g/cm3(Predicted) |
沸点 | 527.3±50.0 °C(Predicted) |
溶解度 | DMSO: < 7.8 mg/mL |
酸度系数 | 13.06±0.20(Predicted) |
存储条件 | -20℃ |
体外研究 | GSK-5959 (3a) also displays selectivity over the closely related family members, BRPF2 (100-fold) and BRPF3 (>1000-fold). GSK-5959 (3a) exhibits an EC 50 = 0.98 μM) in cellular NanoBRET assay. GSK-5959 has no effect on TRIM24 SUMOylation. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.535 ml | 12.675 ml | 25.351 ml |
5 mM | 0.507 ml | 2.535 ml | 5.07 ml |
10 mM | 0.254 ml | 1.268 ml | 2.535 ml |
5 mM | 0.051 ml | 0.254 ml | 0.507 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!